Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aimei Health Technology Co., Ltd ( (AFJK) ) has shared an announcement.
Aimei Health Technology Co., Ltd deposited $34,330.96 into its trust account to extend the deadline to complete its initial business combination by one month, moving the termination date from March 6, 2026, to April 6, 2026. This represents the company’s sixteenth permitted extension and underscores its ongoing efforts to preserve the SPAC structure while pursuing a merger with a suitable target.
On March 4, 2026, the company issued an unsecured promissory note for the same amount to its sponsor Aimei Health Ltd and to United Hydrogen Group Inc., with each contributing half of the funds to support the extension payment. The note, which bears no interest and is payable upon completion of the planned business combination with United Hydrogen, may be converted at the payees’ option into private units, highlighting continued financial backing from insiders and the prospective merger partner.
More about Aimei Health Technology Co., Ltd
Aimei Health Technology Co., Ltd is a special purpose acquisition company (SPAC) that has raised capital from public shareholders and placed the proceeds in a trust account while it seeks to consummate an initial business combination. The company is focused on completing a merger transaction, currently targeting a business combination with United Hydrogen Group Inc. in the Cayman Islands.
Average Trading Volume: 221,258
Technical Sentiment Signal: Buy
Current Market Cap: $205M
Learn more about AFJK stock on TipRanks’ Stock Analysis page.